作者
Daniel R Gomez, Chad Tang, Jianjun Zhang, George R Blumenschein Jr, Mike Hernandez, J Jack Lee, Rong Ye, David A Palma, Alexander V Louie, D Ross Camidge, Robert C Doebele, Ferdinandos Skoulidis, Laurie E Gaspar, James W Welsh, Don L Gibbons, Jose A Karam, Brian D Kavanagh, Anne S Tsao, Boris Sepesi, Stephen G Swisher, John V Heymach
发表日期
2019/6/6
期刊
Journal of Clinical Oncology
卷号
37
期号
18
页码范围
1558
出版商
American Society of Clinical Oncology
简介
PURPOSE
Our previously published findings reported that local consolidative therapy (LCT) with radiotherapy or surgery improved progression-free survival (PFS) and delayed new disease in patients with oligometastatic non–small-cell lung cancer (NSCLC) that did not progress after front-line systemic therapy. Herein, we present the longer-term overall survival (OS) results accompanied by additional secondary end points.
学术搜索中的文章
DR Gomez, C Tang, J Zhang, GR Blumenschein Jr… - Journal of Clinical Oncology, 2019
